Ray Quenneville
Physician Assistant · Fort Collins, CONPI 1730153875
Payments from drug & device makers
Across 127 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$936
- Abbott$370
- GSK$260
- Lilly USA, LLC$107
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$92
- Pfizer$79
- plus $490 from 18 others
What the payments were for
- Food & beverage$2,334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $936 |
| Abbott | 20 | $370 |
| GSK | 15 | $260 |
| Lilly USA, LLC | 6 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $92 |
| Pfizer | 4 | $79 |
| Amgen | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Antares Pharma, Inc. | 2 | $50 |
| Seqirus USA Inc | 2 | $42 |
| Novo Nordisk | 2 | $39 |
| Bayer | 2 | $30 |
| Merck | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Medtronic | 1 | $22 |
| Indivior Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Corium, LLC | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Genentech USA, Inc. | 2 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
How this compares
$2,334 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 23 | $23,165 |
| Repatha SureclickEvolocumab | 13 | $7,168 |
| Fentanyl | 13 | $3,838 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $3,170 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,227 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 79 | $1,723 |
| Divalproex Sodium | 17 | $1,584 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $1,371 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,322 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,206 |
| Testosterone Cypionate | 16 | $967 |
| Levothyroxine Sodium | 125 | $910 |
| Liothyronine Sodium | 18 | $889 |
| Ventolin HfaAlbuterol Sulfate | 16 | $882 |
| Omeprazole | 60 | $776 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $107 | $23,16523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Fort Collins
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
- Christine ZerrLittleton$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.